In vitro - in vivo evaluation of E/R trilayer matrix tablets containing solid dispersion of atorvastatin
Keywords:
Atorvastatin, Carbopol 934P, Geometric, Trilayer matrix tablet, In-vivo bioavailability studiesAbstract
Investigation of in vitro/in vivo behavior of extended release tablets containing solid dispersions of Atorvastatin is the focus of the present research work. Atorvastatin trilayer matrix tablets were prepared by direct compression method and consisted of middle active layer with different grades of hydroxypropylmethylcellulose (HPMC), ethyl cellulose and Carbopol 934P. Barrier layers are prepared with hydrophobic polymers carnauba wax and xanthan gum. Based on the evaluation parameters, drug dissolution profile and release order kinetics HF16 was found to be optimized formulation. The developed drug delivery system provided prolonged drug release rates over a period of 24 h. The release profile of the optimized formulation (HF16) was described by the Zeroorder and best fitted to Higuchi model. FTIR confirmed that there was no chemical interaction between drug and excipients used in the formulation. . In vivo bioavailability studies were conducted for optimized formulation HF16 and reference standard. The optimized formulation of Atorvastatin trilayer matrix tablet was shown significant plasma concentration with extended release and maintained for 24 hrs with patient compliance by reducing the dosage frequency, when compared with reference standard.
References
Fahr A, Liu X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Deliv.2007; 4:403–16. 2. Tapan Kumar Giri, Kulesh Kumar, Amit Alexander, Ajazuddin, Hemant Badwaik, Dulal Krishna Tripathi. A novel and alternative approach to controlled release drug delivery system based on solid dispersion technique, Bulletin of Faculty of Pharmacy, Cairo University, 2012: 50(2):147–159 3. Shajahan A, Pondar S. A flexible technology for modified release of drugs: multilayer tablets. J. Control. Release. 2004; 97: 393–405. 4. Conte U, Maggi L, Colombo P, La Manna A. Multi-layered hydrophilic matrices as constant release devices. J Control Rel. 1993; 26: 39-47. 5. Yihong Qui, Chidambaram N, Kolette F. Design and evaluation of layered diffusional matrices for zero order sustained-release tablets. J Control Rel. 1998; 51: 123-130. 6. Gohel MC, Parikh RK, Padshala MN, Sarvaiya KG, Jena DG. Formulation and optimization of directly compressible isoniazid modified release matrix tablet. IJPS. 2007; 69(5): 640-645. 7. Tobyn MJ, Stani forth JN, Baichwal AR, Mc Call TW. Prediction of physical properties of a novel polysaccharide controlled release system. Int J Pharm. 1996; 128: 113-22. 8. Talukdar MM, Mooter VD, Augustijns P, Maga TT, Verbeke N, Kinget R. In vitro evaluation of xanthan gum as potential excipients for oral controlled release matrix tablet formulation. Int J Pharm. 1998; 169: 105-13. 9. Talukdar MM, Vercammen JP. Evaluation of xanthan gum as a hydrophillic matrix for controlled release dosage forms. Drug Dev Ind Pharm. 1993; 19:1037-46. 10. Hong Wen, Kinam Park. Oral controlled release formulation design and drug delivery, Theory to practice. Wiley publication. New Jercy. 2010; 94-95. 11. Dinesh Kumar Mishra, Dinesh Kumar Jain, Formulation and evaluation of Atorvastatin sustained release matrix tablets. Bulletin of Pharmaceutical Research. 2014; 4(2): 81-5. 12. Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier JP, Piccerelle P. The preparation of orally disintegrating tablets using a hydrophilic waxy binder. Int J. Pharm. 2004; 278(2): 423-33. 13. Yihong Qui, Chidambaram N, Kolette F. Design and evaluation of layered diffusional matrices for zero order sustained-release tablets. J Control Rel. 1998; 51: 123-130. 14. Gohel MC, Parikh RK, Padshala MN, Sarvaiya KG, Jena DG. Formulation and optimization of directly compressible isoniazid modified release matrix tablet. IJPS. 2007; 69(5): 640-645. 15. Balakrishnaiah M, Rama Mohan Gupta V. Solubility Enhancement of Atorvastatin using Solid dispersion technique with novel carriers. Am. J. Pharm Tech Res. 2016; 6(3): 450-466. 16. Entidhar j. A, akkam, abdul rasool , adnan a. Badwan , nawzat d. A- jbour, idal a. Qinna. Development and validation of a sensitive and accurate method for determination of atorvastatin and rosuvastatin in rat plasma by reversed- phase high performance liquid chromatography with uv detection. int j pharm pharm sci. 2011; 5: 211-219.
